title: Response to: 'Infliximab and CT-P13 immunogenicity assessment in PLANETAS and PLANETRA main and extension studies: utility of laboratory methods description' by Francesca Meacci et al.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Braun
mesh_terms: D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals; D000069285:Infliximab
chemical_list: D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals; C000591237:CT-P13; D000069285:Infliximab
keywords: Autoantibodies; Disease Activity; Treatment